<DOC>
	<DOC>NCT00214058</DOC>
	<brief_summary>The purpose of this study is to determine the safety and efficacy of this regimen in women with ovarian or peritoneal cancer</brief_summary>
	<brief_title>Weekly Carboplatin/Docetaxel for Recurrent Ovarian/Peritoneal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Neoplasms, Glandular and Epithelial</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>Recurrent ovarian or peritoneal cancer No prior chemotherapy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
</DOC>